市場調查報告書
商品編碼
1591442
拉丁美洲捐卵 IVF 服務市場規模和預測、區域佔有率、趨勢和成長機會分析報告範圍:按類型、最終用戶和國家分類Latin America Donor Egg IVF Services Market Size and Forecast, Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, End User, and Country |
拉丁美洲捐卵體外受精服務市場規模預計將從2023年的1.3262億美元成長到2031年的2.9110億美元;預計 2023-2031 年複合年成長率為 10.3%。
拉丁美洲已成為國際患者尋求負擔得起的高品質體外受精治療的熱門生育治療目的地。與北美和歐洲相比,拉丁美洲的生育手術成本相對較低,使得服務更容易獲得,吸引了尋求這些治療選擇的本地和國際患者。卓越技術、成本效益和富有同情心的護理的融合使拉丁美洲成為生育治療的理想目的地。墨西哥等國家因其較低的成本和成功的治療結果而吸引了來自美國和其他國家的患者,從而推動了對捐卵服務的需求。
在美國,生育治療通常不包含在保險範圍內,因此價格昂貴且難以獲得,根據自付費用生育患者費用:數據顯示,新的 IVF 週期平均費用高達約 20,000 美元來自多中心預期不孕症隊列。為了獲得護理,前往拉丁美洲的治療目的地是比典型治療費用更經濟、更方便的替代方案,診所可以以四分之一的價格提供體外受精週期,並提供更高品質的護理和更好的患者體驗。拉丁美洲的 IVF 治療比美國或歐洲便宜 70%,且護理品質不受影響。
此外,由於治療成本相對較低,墨西哥已成為醫療旅遊的主要目的地。 Infertility Aide 是一家在全球範圍內聯繫醫生與不孕症患者的機構,該機構報告稱,墨西哥 IVF 的平均總費用(包括藥物、監測以及醫生和醫院的費用)約為 8,000 美元。在墨西哥的醫療旅遊領域,輔助生殖是醫療旅遊的第三大原因。該國為各種輔助生殖技術治療提供了有利的監管環境。拉丁美洲沒有法律限制或禁止體外受精治療、卵子捐贈、性別選擇、基因篩檢或精子捐贈。
巴西也是醫療旅遊的主要中心,並正在擴大藥物的供應,包括生育治療。該國共有 150 個提供不孕症治療的機構。與美國和西歐相比,這些治療的相關費用非常實惠。因此,負擔能力、優質護理、尋求生育治療(包括捐卵體外受精)的國際患者的湧入以及生育旅遊的不斷成長正在推動拉丁美洲捐卵體外受精治療服務市場的擴張。
基於類型的見解
拉丁美洲捐卵體外受精服務市場依類型分為冷凍捐卵和新鮮捐卵。 2023 年,冷凍捐卵細分市場在拉丁美洲捐卵 IVF 服務市場佔有率中佔據更大佔有率。
基於最終用戶的見解
拉丁美洲捐卵體外受精服務市場依最終用戶分類為生育診所及體外受精中心、醫院等。 2023 年,生育診所和 IVF 中心細分市場佔據了拉丁美洲捐卵 IVF 服務市場佔有率最大的佔有率。
拉丁美洲捐卵體外受精服務市場受到幾個關鍵因素的推動,例如夫婦不孕率的上升以及輔助生殖技術的接受度不斷提高,導致對這些服務的需求增加。此外,拉丁美洲的體外受精治療費用普遍低於已開發國家,使其成為當地和國際患者的理想選擇。生育旅遊的興起進一步為擴大捐卵體外受精服務創造了良好的環境,隨著來自生育法律限制性國家的個人尋求負擔得起且易於獲得的生育解決方案,促進了市場成長。 2023 年,巴西佔最大市場佔有率。例如,根據Macrotrends發布的《1950-2024年巴西出生率》,全國2024年的出生率為每1000人12.580人,比2023年的每1000人12.806人下降1.76%。隨著越來越多的夫婦面臨受孕困難,對捐卵體外受精服務的需求激增。根據2021 年9 月發表的一篇題為《輔助生殖技術和生育力保存的限制》的文章,2012 年至2019 年間,該國進行的試管受精週期數量有所增加,巴西註冊診所數量增加了63%,冷凍胚胎的數量增加了三倍。全國註冊的 IVF 診所數量從 120 家增加到 183 家(資料來源:ANVISA,2020 年)。此外,巴西的受精率顯示該國的輔助生殖服務是有效的,達到了國際標準。根據全國胚胎生產系統第十二次報告的資料,該國平均受精成功率為76%,符合國際文獻建議的65%至75%的品質標準(資料來源:SisEmbrio,2019)。
此外,巴西擁有輔助生殖技術的支持性法律架構。巴西法規支持匿名卵子捐贈,為患者提供廣泛的潛在捐贈者,同時保持捐贈者的機密性。雖然禁止向捐贈者付費,但該國許多診所提供費用補償,這鼓勵更多的婦女作為捐贈者參與。
此外,2023 年 9 月,生殖科技公司 AIVF 在巴西戈亞尼亞的多學科生育診所 Perfetto 推出了第一個人工智慧驅動的 IVF 作業系統。 AIVF 開發了一種名為 EMA by AIVF 的專有人工智慧驅動作業系統,旨在幫助 IVF 設施加強患者與臨床醫生的溝通、最佳化工作流程並做出更好的臨床決策。 AIVF的擴張極大地滿足了巴西對輔助生殖技術日益成長的需求。
美國國立衛生研究院 (NIH)、不列顛哥倫比亞醫學雜誌、Wiley 和 Fertility and Sterility 是在準備拉丁美洲捐卵 IVF 服務市場報告時參考的主要和次要來源。
The Latin America donor egg IVF services market size is expected to grow from US$ 132.62 million in 2023 and is projected to reach US$ 291.10 million by 2031; it is expected to register a CAGR of 10.3% during 2023-2031.
Latin America has become a popular fertility treatment destination for international patients seeking affordable and high-quality IVF treatments. The relatively lower cost of fertility procedures in Latin America compared to North America and Europe makes the services more accessible, attracting both local and international patients seeking these treatment options. The fusion of technological excellence, cost-effectiveness, and compassionate care makes Latin America an ideal destination for fertility treatments. Countries such as Mexico attract patients from the US and other countries due to lower costs and successful treatment outcomes, which drive demand for donor egg services.
In the US, fertility treatments are most often not covered by insurance, making them price-intensive and inaccessible, with a fresh IVF cycle costing up to ~US$ 20,000 on average, according to the Out-of-Pocket Fertility Patient Expense: Data from a Multicenter Prospective Infertility Cohort. In order to access care, traveling to treatment destinations in Latin America is a more budget-friendly and convenient alternative to typical treatment costs, where clinics can offer IVF cycles at a quarter of the price with greater quality of care and better patient experience. IVF treatments in Latin America can be as much as 70% cheaper than in the US or Europe without compromising the quality of care.
Moreover, Mexico has established itself as a leading destination for medical tourism due to the relatively low treatment costs. Infertility Aide, an agency that links doctors with infertility patients globally, reports that the total average cost of IVF in Mexico, covering medications, monitoring, and fees for doctors and hospitals, is around US$ 8,000. Within Mexico's medical tourism sector, assisted reproduction is the 3rd top reason for medical travel. The country has favorable regulatory environments for the wide range of assisted reproductive technology treatments. There is no law in LATAM that restricts or prohibits IVF treatments, egg donation, gender selection, genetic screening, or sperm donation.
Brazil also has been a major center for medical tourism and is expanding the availability of medication, including fertility treatment. The country has a total of 150 facilities offering treatments for infertility. The costs associated with these treatments are highly affordable compared to those of the US and Western Europe. Therefore, affordability, quality care, influx of international patients seeking fertility treatments (including donor egg IVF), and the rising growth of fertility tourism are fueling the expansion of the donor egg IVF treatment services market in Latin America.
Type-Based Insights
The Latin America donor egg IVF services market, by type, is bifurcated into frozen donor egg and fresh donor egg. The frozen donor egg segment held a larger share in the Latin America donor egg IVF services market share in 2023.
End User-Based Insights
The Latin America donor egg IVF services market, by end user, is segmented into fertility clinics and IVF centers, hospitals, and others. The fertility clinics and IVF centers segment held the largest Latin America donor egg IVF services market share in 2023.
The Latin America donor egg IVF services market is driven by several key factors, such as increasing infertility rates among couples coupled with a growing acceptance of assisted reproductive technologies, which has led to heightened demand for these services. Additionally, the cost of IVF treatments in Latin America is generally lower than in developed countries, making it an ideal option for both local and international patients. The rise of fertility tourism further creates a robust environment for the expansion of donor egg IVF services, enhancing market growth as individuals from nations with restrictive reproductive laws seek affordable and accessible fertility solutions. Brazil held the largest share of the market in 2023. The declining birth rate is influencing the growth of infertility treatment across the country. For instance, according to the Brazil Birth Rate 1950-2024 published by Macrotrends, the nation's birth rate in 2024 is 12.580 births per 1,000 people, a 1.76% decline from 2023, which was 12.806 births per 1,000 people. As more couples face challenges in conceiving, the demand for donor egg IVF services has surged. As per an article titled "Restricted access to assisted reproductive technology and fertility preservation," published in September 2021, the number of IVF cycles conducted in the country improved between 2012 and 2019, the number of registered clinics in Brazil increased by 63%, and the number of frozen embryos increased threefold. The number of IVF clinics registered in the nation rose from 120 to 183 (Source: ANVISA, 2020). Additionally, fertilization rates in Brazil indicate that the country's assisted reproduction services are effective, achieving international standards. The country's average fertilization success rate was 76%, which is within the quality standards recommended in the international literature, ranging from 65% to 75%, as per the data from the 12th report of the National System of Embryo Production (Source: SisEmbrio, 2019).
In addition, Brazil has a supportive legal framework for assisted reproductive technologies. The Brazilian regulations support anonymous egg donation, providing patients with a broad pool of potential donors while maintaining donor confidentiality. While paying donors is prohibited, many clinics in the country provide compensation for expenses, which encourages more women to participate as donors.
Moreover, in September 2023, the first AI-powered IVF operating system was introduced in Brazil at Perfetto, a multidisciplinary fertility clinic in Goiania, by the reproductive technology business AIVF. A proprietary AI-powered operating system called EMA by AIVF was developed to assist IVF facilities in strengthening patient-clinician communications, optimizing workflows, and making better clinical decisions. The expansion of AIVF greatly meets Brazil's rising need for assisted reproductive technologies.
The National Institutes of Health (NIH), British Columbia Medical Journal, Wiley, and Fertility and Sterility are among the primary and secondary sources referred to while preparing the Latin America donor egg IVF services market report.